Many pharmaceutical companies say attacking health inequities is a strategic objective, but addressing the topic is hard to do. Why is this so? 

This episode's guest, Elisa Remoundos,  Senior Vice President and Group Creative Director for Entrée Health, believes that for pharma and market access to tackle health inequities they need to rethink the social determinants of health that can have a huge impact on adherence, compliance, health outcomes, and societal burdens.

Elisa also wrote about SDoH and market acccess here. 

Follow Elisa on LinkedIn. 

Follow Valuate on LinkedIn or learn more here.